Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1014643

Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study


(CATSTAT-HF) Borovac, Josip Anđelo; Glavaš, Duška; Sušilović Grabovac, Zora; Šupe Domić, Daniela; D'Amario, Domenico; Božić, Joško
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study // Journal of Clinical Medicine, 8 (2019), 8; 1132, 18 doi:10.3390/jcm8081132 (međunarodna recenzija, kratko priopcenje, znanstveni)


CROSBI ID: 1014643 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study

Autori
Borovac, Josip Anđelo ; Glavaš, Duška ; Sušilović Grabovac, Zora ; Šupe Domić, Daniela ; D'Amario, Domenico ; Božić, Joško

Kolaboracija
CATSTAT-HF

Izvornik
Journal of Clinical Medicine (2304-6775) 8 (2019), 8; 1132, 18

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni

Ključne riječi
acute myocardial infarction ; biomarkers ; catestatin ; coronary artery disease ; heart failure ; heart failure decompensation ; left ventricular ejection fraction ; troponin ; NT-proBNP ; NYHA functional class

Sažetak
The role of catestatin (CST) in acutely decompensated heart failure (ADHF) and myocardial infarction (MI) is poorly elucidated. Due to the implicated role of CST in the regulation of neurohumoral activity, the goals of the study were to determine CST serum levels among ninety consecutively enrolled ADHF patients, with respect to the MI history and left ventricular ejection fraction (LVEF) and to examine its association with clinical, echocardiographic, and laboratory parameters. CST levels were higher among ADHF patients with MI history, compared to those without (8.94 ± 6.39 vs. 4.90 ± 2.74 ng/mL, p = 0.001). CST serum levels did not differ among patients with reduced, midrange, and preserved LVEF (7.74 ± 5.64 vs. 5.75 ± 4.19 vs. 5.35 ± 2.77 ng/mL, p = 0.143, respectively). In the multivariable linear regression analysis, CST independently correlated with the NYHA class (β = 0.491, p < 0.001), waist-to-hip ratio (WHR) (β = −0.237, p = 0.026), HbA1c (β = −0.235, p = 0.027), LDL (β = −0.231, p = 0.029), non-HDL cholesterol (β = −0.237, p = 0.026), hs-cTnI (β = −0.221, p = 0.030), and the admission and resting heart rate (β = −0.201, p = 0.036 and β = −0.242, p = 0.030), and was in positive association with most echocardiographic parameters. In conclusion, CST levels were increased in ADHF patients with MI and were overall associated with a favorable cardiometabolic profile but at the same time reflected advanced symptomatic burden (CATSTAT-HF ClinicalTrials.gov number, NCT03389386).

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
KBC Split,
Medicinski fakultet, Split,
Sveučilište u Splitu,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija

Poveznice na cjeloviti tekst rada:

doi www.mdpi.com www.mdpi.com

Citiraj ovu publikaciju:

(CATSTAT-HF) Borovac, Josip Anđelo; Glavaš, Duška; Sušilović Grabovac, Zora; Šupe Domić, Daniela; D'Amario, Domenico; Božić, Joško
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study // Journal of Clinical Medicine, 8 (2019), 8; 1132, 18 doi:10.3390/jcm8081132 (međunarodna recenzija, kratko priopcenje, znanstveni)
(CATSTAT-HF) (CATSTAT-HF) Borovac, J., Glavaš, D., Sušilović Grabovac, Z., Šupe Domić, D., D'Amario, D. & Božić, J. (2019) Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study. Journal of Clinical Medicine, 8 (8), 1132, 18 doi:10.3390/jcm8081132.
@article{article, author = {Borovac, Josip An\djelo and Glava\v{s}, Du\v{s}ka and Su\v{s}ilovi\'{c} Grabovac, Zora and \v{S}upe Domi\'{c}, Daniela and D'Amario, Domenico and Bo\v{z}i\'{c}, Jo\v{s}ko}, year = {2019}, pages = {18}, DOI = {10.3390/jcm8081132}, chapter = {1132}, keywords = {acute myocardial infarction, biomarkers, catestatin, coronary artery disease, heart failure, heart failure decompensation, left ventricular ejection fraction, troponin, NT-proBNP, NYHA functional class}, journal = {Journal of Clinical Medicine}, doi = {10.3390/jcm8081132}, volume = {8}, number = {8}, issn = {2304-6775}, title = {Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study}, keyword = {acute myocardial infarction, biomarkers, catestatin, coronary artery disease, heart failure, heart failure decompensation, left ventricular ejection fraction, troponin, NT-proBNP, NYHA functional class}, chapternumber = {1132} }
@article{article, author = {Borovac, Josip An\djelo and Glava\v{s}, Du\v{s}ka and Su\v{s}ilovi\'{c} Grabovac, Zora and \v{S}upe Domi\'{c}, Daniela and D'Amario, Domenico and Bo\v{z}i\'{c}, Jo\v{s}ko}, year = {2019}, pages = {18}, DOI = {10.3390/jcm8081132}, chapter = {1132}, keywords = {acute myocardial infarction, biomarkers, catestatin, coronary artery disease, heart failure, heart failure decompensation, left ventricular ejection fraction, troponin, NT-proBNP, NYHA functional class}, journal = {Journal of Clinical Medicine}, doi = {10.3390/jcm8081132}, volume = {8}, number = {8}, issn = {2304-6775}, title = {Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study}, keyword = {acute myocardial infarction, biomarkers, catestatin, coronary artery disease, heart failure, heart failure decompensation, left ventricular ejection fraction, troponin, NT-proBNP, NYHA functional class}, chapternumber = {1132} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Emerging Sources Citation Index (ESCI)
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font